On June 16, 2026, Nano Dimension Ltd. issued a press release providing additional information regarding a proposed business combination with Infinite Epigenetics, Inc. The company has filed a preliminary proxy statement for an extraordinary general meeting of shareholders to consider a non-binding advisory resolution on the continuation of its strategic alternatives review process. If a definitive agreement is executed, Nano expects to file a registration statement on Form S-4 containing a proxy statement and prospectus. Nano Dimension operates in the additive manufacturing industry, specializing in 3D printing technology.
